Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating $21.24 +0.87 (+4.27%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.68Holdings in PILL have an aggregate rating of Moderate Buy based on 241 analyst ratings issued in the past year covering 21 companies (31.6% of the portfolio).PILL Aggregate Price Target$21.24High Prediction$21.24Average Prediction$21.24Low Prediction$21.24Holdings in PILL have an aggregate price target of $21.24 and a range of $21.24 to $21.24 covering 21 companies (31.6% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 PILL Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.62%CRNXCrinetics Pharmaceuticals$84.70+0.3%1.9416 of 5 stars2.24$81.00 -4.4%17Positive News2.22%MBXMBX Biosciences$68.57+2.2%2.2015 of 5 stars2.75$75.63 10.3%122.04%ATAIAtai Beckley$7.26+0.1%3.775 of 5 stars2.20$10.56 45.4%15Positive NewsEarnings ReportAnalyst DowngradeShort Interest Decrease1.95%DFTXDefinium Therapeutics$42.63-2.9%3.0394 of 5 stars3.00$62.14 45.8%19Trending NewsAnalyst ForecastAnalyst RevisionGap Down1.57%AMLXAmylyx Pharmaceuticals$21.63-3.8%2.6086 of 5 stars2.90$25.38 17.3%10News CoverageAnalyst Revision1.54%ELVNEnliven Therapeutics$58.82+1.3%3.2297 of 5 stars2.71$72.67 23.5%71.54%NUVBNuvation Bio$6.24+2.2%3.7435 of 5 stars2.64$13.00 108.5%11Analyst RevisionHigh Trading Volume1.45%TRVITrevi Therapeutics$18.46+1.7%2.7257 of 5 stars3.00$27.08 46.7%13Analyst ForecastAnalyst Revision1.43%LQDALiquidia$74.44+3.2%4.6227 of 5 stars2.64$98.08 31.8%11Trending NewsEarnings ReportAnalyst DowngradeAnalyst Revision1.41%ALMSAlumis$25.31+3.7%3.6714 of 5 stars2.83$40.30 59.2%12Earnings ReportAnalyst ForecastGap Down1.34%NKTRNektar Therapeutics$73.02-3.8%2.8054 of 5 stars2.75$150.00 105.4%12Trending NewsEarnings ReportGap Down1.34%AMRXAmneal Pharmaceuticals$18.15+5.1%3.3078 of 5 stars3.00$17.67 -2.7%8Analyst DowngradeInsider Trade1.30%EWTXEdgewise Therapeutics$44.17+2.3%2.0316 of 5 stars2.82$49.08 11.1%11Trending NewsAnalyst ForecastInsider Trade1.28%CORTCorcept Therapeutics$114.47+3.6%2.7753 of 5 stars2.63$119.17 4.1%8Insider Trade1.25%LGNDLigand Pharmaceuticals$294.60+2.0%3.7938 of 5 stars3.00$335.75 14.0%9Analyst Upgrade1.24%ELANElanco Animal Health$23.64+5.0%4.2688 of 5 stars2.77$29.09 23.1%13Insider Trade1.24%MANEVeradermics$113.18+2.0%2.5905 of 5 stars2.67$153.00 35.2%9Earnings Report1.23%OMEROmeros$17.19-0.9%3.7108 of 5 stars2.67$38.00 121.1%6Trending NewsEarnings ReportOptions VolumeAnalyst RevisionHigh Trading Volume1.22%ETONEton Pharmaceuticals$58.86+44.3%3.3472 of 5 stars2.33$67.50 14.7%6Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap UpHigh Trading Volume1.22%BMYBristol Myers Squibb$63.86-1.2%4.2319 of 5 stars2.52$66.06 3.4%25Trending NewsAnalyst Revision1.21%VTRSViatris$16.23+1.2%2.5827 of 5 stars2.57$17.50 7.8%7Positive News This page (NYSEARCA:PILL) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersBuy These Stocks Before August 31stKeith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwi...TradeSmith | SponsoredHow a rare metal shortage sent gains up 2512 percentIn 2010, a rare earth metal called dysprosium surged 2,512 percent in two and a half years after China cut exp...Awesomely | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
